Why Moving Hurts: The Biology of Muscle Pain and Stiffness in ME/CFS
Peeling potatoes. Opening a jar. Holding a phone to your ear for three minutes.
For someone with severe ME/CFS, these tasks can produce more pain and exhaustion than a healthy person experiences after an hour of vigorous exercise. And the pain doesn’t peak during the activity — it peaks hours later, when the person has long since stopped and is lying in bed wondering what went wrong.
This is not weakness. It is not deconditioning. It is not catastrophizing. The biology is now understood well enough to explain, specifically and mechanistically, why movement in ME/CFS causes pain, stiffness, and disproportionate exhaustion — even in the muscles themselves.
1 First: why the energy problem alone isn’t enough to explain this
Most discussions of ME/CFS focus, correctly, on energy production failure. Impaired mitochondrial function reduces ATP output. The body runs short of its molecular fuel. This is real and well-documented.
But energy deficit alone doesn’t explain pain. It doesn’t explain why muscles feel like they’re burning when you weren’t exercising hard. It doesn’t explain why joints ache without any sign of arthritis. It doesn’t explain why even light pressure on a muscle — a massage, someone brushing past you — can feel intensely unpleasant.
Understanding why movement hurts requires looking at four distinct layers: what’s happening inside the muscles themselves, what’s happening in the blood supply to those muscles, what’s happening in the connective tissue around joints and nerves, and what’s happening in the brain that interprets all of these signals. In ME/CFS, all four layers are disrupted simultaneously.
2 Layer 1: Muscles that signal “danger” even at rest
In healthy muscles, normal movement generates metabolic byproducts — lactic acid, protons, ATP release — that are quickly cleared. Pain only occurs when these accumulate beyond a threshold, which typically requires sustained high-intensity exercise.
In ME/CFS, the threshold is already being crossed at rest.
The problem starts in the mitochondria. When mitochondrial ATP synthesis is impaired, cells can’t produce energy efficiently through oxidative phosphorylation. They shift toward glycolysis — the faster, dirtier backup pathway that generates energy without oxygen but produces more lactic acid as a byproduct. Research using exercise testing confirms that ME/CFS patients switch to anaerobic metabolism at exercise intensities far below what would trigger this in healthy individuals or in deconditioned people.
The result: even mild movements — peeling a potato, holding utensils, gripping a steering wheel — push muscle cells into a metabolic state that healthy muscles only reach under significant strain. The muscles are producing an accumulation of lactate, protons (acidosis), and metabolic intermediates like succinate, even during activities that require minimal effort.
These are not inert byproducts. They are chemical signals that directly activate pain receptors in muscle tissue.
Three nociceptor systems respond:
Acid-sensing ion channels (ASIC3). These channels on muscle nerve endings respond specifically to the combination of low pH, elevated lactate, and elevated ATP — a signature of ischemic or metabolically stressed muscle. Crucially, ASIC3 responds most strongly to the combination of these signals, functioning as an integrative danger sensor rather than a simple pain switch. In healthy exercise, this combination occurs only at high intensity. In ME/CFS, resting muscle metabolism approximates this danger signature. And after any movement, ASIC3 gene expression in circulating immune cells is significantly elevated in ME/CFS patients, remaining raised for 48 hours — a measurable trace of the activation that healthy people don’t show.
Purinergic P2X receptors. When cells are metabolically stressed, they release ATP into the extracellular space as a distress signal. This extracellular ATP activates P2X3 receptors on muscle nerve endings, producing deep aching pain. In ME/CFS, where ATP metabolism is disrupted at baseline, resting extracellular ATP levels may be chronically elevated — meaning the pain signal that healthy muscles only generate during exertion may be present continuously at lower levels.
TRPV1 (the capsaicin receptor). Proton accumulation in metabolically active tissue sensitizes TRPV1, lowering pain thresholds for both mechanical pressure and temperature. This is why muscles in ME/CFS can feel sore to the touch — the receptor that mediates burning pain has been sensitized by the acidic, oxidatively stressed environment produced by a metabolism running inefficiently. TRPV1 is also temperature-gated: it normally activates above roughly 43°C, but in a sensitized state — with its threshold already lowered by acidosis and oxidative stress — normal body temperature, a warm room, or mild exertion-generated heat can be enough to push it into activation. This is why many ME/CFS patients report that warmth dramatically worsens muscular pain and aching, while cooling the skin provides temporary relief: temperature is not just a comfort variable, it is a direct input to an already-primed nociceptor system.
This is metabolic nociception: pain generated not by injury or inflammation in the conventional sense, but by the chemical environment created when cells can’t produce energy efficiently. The muscles are not damaged in the way a sprain is damaged. They are broadcasting a danger signal because their internal chemistry is wrong.
3 Layer 2: The microvascular problem — ischemia without exertion
Compounding the metabolic picture is a vascular one.
ME/CFS involves endothelial dysfunction — impairment of the cells that line blood vessels. In muscles, this means the fine capillary networks that deliver oxygen to working tissue fail to respond normally to the demands of movement. Evidence from vascular studies indicates that intramuscular microvascular recruitment — the normal process of opening more capillaries when a muscle needs more blood — is impaired in ME/CFS.
The consequence is focal ischemia: patches of muscle receiving insufficient oxygen even during mild activity. Each of these ischemic episodes generates the same chemical signature that ASIC3 and P2X receptors respond to — low pH, elevated lactate, extracellular ATP — but now as a consequence of poor oxygen delivery rather than simply poor energy production. Two independent mechanisms are converging on the same nociceptor systems simultaneously.
There is also a reperfusion component. When blood flow briefly restores to ischemic tissue, it generates a burst of reactive oxygen species (ROS) — free radicals that activate further nociceptors and damage local tissue. In ME/CFS, where systemic ROS production is already elevated (the mitochondrial electron transport chain leaks electrons at several times the normal rate), this reperfusion stress adds to an already burdened oxidative environment.
This mechanism also explains why ME/CFS muscle pain fluctuates unpredictably. Autonomic dysfunction — which affects most ME/CFS patients — alters blood flow patterns with posture, stress, and temperature. A muscle that had adequate perfusion while the person was lying down may become relatively ischemic when they stand or sit upright. The pain can appear to have no clear relationship to what the person is doing, because it’s responding to vascular changes driven by autonomic instability rather than to muscular effort directly.
4 Layer 3: Connective tissue — where joint stiffness and body-wide aching come from
The aching-around-joints that many ME/CFS patients describe — not quite joint pain, not quite muscle pain, but a diffuse soreness in the surrounding tissue — has a specific anatomical explanation.
Mast cells, part of the immune system, are concentrated in periarticular tissue: the joint capsule, the synovium, the ligaments surrounding joints. In a subset of ME/CFS patients — estimated at 15–25% — mast cell activation syndrome (MCAS) is a recognized comorbidity. But even without a formal MCAS diagnosis, mast cell involvement is thought to contribute to symptoms in a broader proportion of patients.
When these periarticular mast cells activate, they release histamine, prostaglandin D₂, and substance P directly into the joint microenvironment. The result resembles inflammatory arthritis: joints feel swollen, stiff, and painful. Inflammatory markers in the blood are normal. Imaging shows nothing. But the joint feels inflamed because the local tissue chemistry is producing the same pain and stiffness signals that arthritis would — through a different mechanism.
Movement stiffness in the morning, or after rest, follows from this: mast cell mediators accumulate in the periarticular tissue during inactivity and require movement to disperse. But that movement, in ME/CFS, triggers the metabolic nociception in the muscles themselves. The person is caught between stiffness from rest and pain from movement — which is why simply “moving more” is not therapeutic advice. It’s a description of the problem.
The fascia — the connective tissue that wraps muscles, septa, tendons, and periosteum — is also richly innervated and contains mast cell populations. Every movement creates tension in fascial layers, which normally causes no pain. In ME/CFS, with sensitized nociceptors and activated mast cells in these tissues, normal fascial tension during movement becomes a pain signal. Peeling vegetables requires sustained grip and forearm movement; the fascia of the forearm is being repeatedly tensioned. In someone with ME/CFS, that continuous low-level input can be enough to generate significant pain.
5 Layer 4: The nervous system that amplifies everything
Everything described above generates genuine peripheral pain signals. But in ME/CFS, those signals don’t arrive at the brain and get processed normally. They arrive at a central nervous system that has been globally sensitized.
Central sensitization is a state in which the pain-processing neurons of the spinal cord and brain have been “turned up” — their thresholds lowered, their responses amplified. Wind-up, the technical term for what happens in sensitized dorsal horn neurons, means that repeated small inputs produce progressively larger outputs. A signal that would be a 2 out of 10 in a healthy nervous system becomes a 6 or 7.
Evidence for central sensitization in ME/CFS is direct and objective. Pressure pain thresholds are reduced across all body regions — not just at sites of reported pain. Heat, electrical, and mechanical stimuli all produce amplified pain responses. Conditioned pain modulation — the body’s normal mechanism for inhibiting pain signals using a competing pain input — is absent or markedly blunted. And exercise that normally activates the body’s own pain-suppression pathways instead worsens pain in ME/CFS, while simultaneously upregulating ASIC3, P2X4, and TLR4 gene expression in immune cells for 48 hours afterward.
The physical substrate for this sensitization is partly neuroinflammatory. Activated microglia — the brain’s immune cells — release cytokines and reactive oxygen species that sensitize surrounding pain-processing neurons. PET imaging in ME/CFS shows 45–199% elevated microglial activation markers in the cingulate cortex, hippocampus, amygdala, thalamus, and brainstem — regions involved in pain processing, not just cognition. The neuroinflammation driving brain fog and unrefreshing sleep is the same neuroinflammation sustaining the sensitized pain state.
There is also a kynurenine pathway contribution. When the immune system is chronically active, it converts tryptophan toward quinolinic acid rather than serotonin. Quinolinic acid is an NMDA receptor agonist — it activates exactly the receptor type that drives wind-up in dorsal horn pain neurons. Neuroinflammation, immune activation, and central sensitization are connected through a molecular pathway that links the immune state of the body directly to the pain threshold of the nervous system.
The practical consequence: when peripheral pain signals from metabolically stressed muscles arrive at a centrally sensitized spinal cord, they are amplified before even reaching the brain. The brain’s interpretation starts from an already-elevated baseline. A task that generates mild peripheral nociceptor activity produces a pain experience disproportionate to the tissue event. This is not psychological amplification — it is neurological amplification, with a measurable physical substrate.
6 Why the pain peaks after, not during
The timing pattern — relative tolerance during activity, intense pain and exhaustion in the hours and days that follow — is explained by the inflammatory response to the metabolic disturbance.
During movement, ASIC3, P2X, and TRPV1 receptors activate, but the nervous system is managing the incoming signals in real time. The bigger event comes afterward. The metabolic disruption — acidosis, ROS generation, microvascular ischemia-reperfusion — triggers an immune response. TLR4 (a pattern-recognition receptor on immune cells) responds to the danger-associated signals, activating the NF-κB inflammatory cascade. Pro-inflammatory cytokines — IL-1β, IFN-α — are produced, peaking 6–24 hours after exertion in ME/CFS patients, at levels and timescales that don’t occur in healthy controls or in deconditioned people. These cytokines cross into the brain (via vagal nerve pathways, circumventricular organs, and transport across the blood-brain barrier), activating the sickness behavior program and further amplifying central sensitization.
The characteristic 12–72 hour delay of post-exertional malaise isn’t mysterious when understood this way. The movement was the trigger. The pain and exhaustion are the secondary damage wave — the immune and inflammatory response to the metabolic disruption that the movement caused.
This is also why “pushing through” is not a path to adaptation. In a healthy person, the inflammatory response to exercise promotes mitochondrial biogenesis, improved vascular recruitment, and stronger connective tissue over time. In ME/CFS, the impaired recovery machinery means each exertion episode causes damage that cannot be fully repaired before the next one. The system doesn’t adapt upward — it degrades.
7 The trembling — why muscles shake during and after effort
Many people with ME/CFS describe a characteristic trembling that appears during or shortly after activity: hands shaking after holding something, legs trembling after standing, arms unsteady after a few minutes of use. It’s often described as feeling “weak and shaky,” as if the muscles have suddenly run out of something — which is precisely what is happening, though the mechanism is more complex than simple exhaustion.
Motor unit recruitment failure during effort. In healthy muscles, slow-twitch muscle fibers (Type I) handle most sustained, low-intensity work — they are mitochondria-rich and fatigue-resistant. Fast-twitch fibers (Type II) are recruited only when demands increase. In ME/CFS, where mitochondrial function in slow-twitch fibers is impaired, those fibers fail to sustain even light loads. The nervous system compensates by recruiting fast-twitch fibers prematurely — fibers that are less efficient, fatigue more rapidly, and produce more metabolic waste per unit of work. This premature fast-twitch recruitment creates a characteristic pattern: trembling and unsteadiness during an activity that should be well within capacity, appearing earlier than effort level would predict, because the fiber population actually doing the work is the wrong one for the task. The hands that begin shaking while still holding the phone — not after putting it down — are showing this recruitment mismatch in real time.
The ATP floor problem. Motor neurons — the nerve cells that command muscle fibers to contract — require a precise, stable supply of ATP to maintain their resting membrane potential and fire in coordinated bursts. When ATP drops below a functional threshold, the sodium-potassium pumps that maintain this potential begin to fail intermittently. The result is irregular, uncoordinated firing: muscle fibers that should be activating in smooth, synchronized waves instead fire inconsistently. This produces visible trembling. In healthy muscles, exercise depletion is temporary and cleared within minutes. In ME/CFS, where mitochondrial production is already impaired and the ATP pool is shallower, even mild activity can drop local ATP to the level where this instability occurs — and recovery is slow.
Dopamine and basal ganglia motor control. The basal ganglia — deep brain structures critical for smooth, coordinated movement — are metabolically vulnerable and dopamine-dependent. In ME/CFS, PET imaging shows reduced glucose metabolism in basal ganglia regions, and direct CSF measurement (from the NIH deep phenotyping study) documents depleted dopamine metabolites. Reduced basal ganglia dopamine availability correlates directly with mental fatigue severity in ME/CFS patients. Beyond fatigue, the basal ganglia are responsible for motor smoothing: they suppress unwanted movements and regulate the timing and amplitude of voluntary action. When basal ganglia function is impaired — by hypometabolism and dopamine depletion — this motor smoothing fails. The trembling associated with sustained activity in ME/CFS may reflect, in part, a failure of this motor-suppression system rather than a pure muscular exhaustion phenomenon.
The excitatory/inhibitory imbalance. Magnetic resonance spectroscopy in ME/CFS finds elevated glutamate (excitatory) alongside reduced GABA (inhibitory) in several brain regions. This imbalance matters for motor control because the motor cortex and spinal motor circuits depend on precisely calibrated inhibitory tone to produce smooth, controlled movement. An excess of excitatory drive relative to inhibitory control produces instability in motor output — manifesting as tremor or postural unsteadiness. The same neuroinflammatory conditions that increase quinolinic acid (an NMDA receptor agonist, amplifying excitation) are associated with impaired GABAergic interneuron function, pushing the balance further toward excitation.
The autonomic component. Some of the trembling in ME/CFS — particularly the whole-body shaking that can follow exertion or standing — has an autonomic dimension. The sympathetic nervous system, which is chronically dysregulated in ME/CFS, can produce tremor-like states through excessive norepinephrine signaling to muscle tissue. But in ME/CFS, the picture is inverted: central norepinephrine is depleted (direct CSF measurement shows reduced norepinephrine metabolites), while peripheral autonomic regulation is erratic. After exertion, some patients experience a surge of sympathetic activation as the body attempts to compensate for falling blood pressure or falling blood glucose — this compensatory sympathetic response can manifest as shaking that feels distinct from muscular weakness.
What the trembling signals. The shaking after peeling those potatoes is not a dramatic exaggeration. It is the visible external sign of several simultaneous failures: ATP instability in motor neurons, basal ganglia smoothing circuits running on depleted dopamine, excitatory/inhibitory imbalance in motor control pathways, and an autonomic system oscillating between under- and over-compensation. The muscles are broadcasting, in the most direct way possible, that the system has been pushed beyond what its current energy and neurological state can sustain.
8 Cramps — when the muscle seizes
Distinct from the deep aching of metabolic nociception and from the unsteadiness of trembling, cramps are a different phenomenon: a sudden, involuntary, sustained contraction of a muscle or muscle group that produces intense localized pain and visible or palpable hardening of the tissue. Many ME/CFS patients experience them with a frequency and intensity far beyond what their activity level would predict.
The ATP-Na⁺/K⁺-ATPase connection. Muscle contraction requires calcium release; muscle relaxation requires calcium reuptake into the sarcoplasmic reticulum — an active, ATP-dependent process. The sodium-potassium pump (Na⁺/K⁺-ATPase), which maintains the electrochemical gradients essential for a muscle fiber to repolarize after firing, is also ATP-dependent. When ATP is depleted, both of these systems fail together: the muscle fires but cannot efficiently reset. The result is sustained, uncontrolled contraction. In healthy muscles, this only occurs at extreme exercise intensities. In ME/CFS, where the ATP pool is shallower and mitochondrial replenishment is impaired, the threshold for this failure is crossed at much lower workloads — or even at rest, during the night, when positional changes shift blood flow and alter local metabolic conditions.
The hyperexcitability contribution. The excitatory/inhibitory imbalance described in the trembling section — elevated glutamate, reduced GABA, quinolinic acid driving NMDA receptor activation — also affects spinal motor circuits. Hyperexcitable motor neurons discharge at lower thresholds and are more prone to the sustained firing that produces cramps. A motor neuron that in a healthy nervous system requires a significant stimulus to fire repetitively will, in a centrally sensitized state, sustain that firing with minimal provocation. This is why ME/CFS cramps often seem to have no clear trigger — they are arising from a nervous system with its motor excitability threshold already pushed down.
Electrolytes, dysautonomia, and the volume problem. POTS and other dysautonomic presentations in ME/CFS are associated with low circulating blood volume and chronic sympathetic activation. Both conditions promote urinary losses of magnesium and potassium — electrolytes that are critical for muscle membrane stability and for normal Na⁺/K⁺-ATPase function. Magnesium deficiency in particular lowers the threshold for sustained motor neuron discharge and impairs calcium reuptake in the sarcoplasmic reticulum. This creates a third, independent pathway converging on the same outcome: muscles that are metabolically vulnerable, neurologically hyperexcitable, and electrolyte-depleted will cramp more readily, more severely, and in response to activities — or inactivities — that would not trouble a healthy person.
What cramps signal. Unlike the aching of metabolic nociception, which represents a genuine danger signal from stressed tissue, cramps are a mechanical dysfunction: the ATP-dependent relaxation machinery failing to release a contraction that would normally terminate in seconds. The pain is real and often severe, but the primary failure is in this relaxation machinery, not in tissue injury. This distinction matters because it explains why stretching a cramping muscle — the instinctive response — sometimes worsens the pain: in a hyperexcitable motor circuit, the stretch reflex can reinforce rather than interrupt the sustained contraction.
9 Why stretching can make things worse
Stretching looks like the obvious solution to stiffness. Loosen the muscles, mobilize the joints, improve circulation. In ME/CFS, this intuition fails — and sometimes badly.
The fascia problem. Fascia is not passive packaging. The thoracolumbar fascia, intramuscular septa, joint capsules, and periosteum are richly innervated with C-fiber and A-delta nociceptors — the same small-fiber pain receptors found throughout the body. These fascial nociceptors are mechanosensitive: they respond to tension. In a healthy person, normal fascial stretch produces no pain because nociceptor thresholds are high. In ME/CFS, where central sensitization has lowered those thresholds system-wide, mechanical tension in fascial tissue that would be painless — or even pleasant — in a healthy person is now within the range that triggers a pain response.
A stretch that gently elongates the hamstrings is generating tension throughout the posterior fascial chain. That tension is transmitted to nociceptors that have been sensitized by neuroinflammation and oxidative stress. The stretch itself becomes a pain input, arriving at a spinal cord already primed to amplify.
TRPA1 and the oxidative stress receptor. One of the pain receptor subtypes expressed in Schwann cells (the cells that insulate nerve fibers) and in nociceptors throughout connective tissue is TRPA1 — the ankyrin 1 channel. Unlike TRPV1, which responds to heat and acid, TRPA1 responds directly to oxidative stress products: reactive oxygen species, 4-hydroxynonenal (a lipid peroxidation product), and acrolein. In ME/CFS, systemic ROS elevation means these tissues are already partially bathed in TRPA1-activating molecules. A stretch that generates mechanical tension and mildly disrupts local tissue — normal at low intensity — releases small amounts of additional oxidative stress products locally. Combined with the pre-existing ROS baseline, this can push TRPA1 across its activation threshold, producing pain from a stretch that would not be painful in oxidatively normal tissue.
Mast cell degranulation from mechanical force. Mast cells, concentrated in the periarticular tissue and throughout connective tissue, can be mechanically activated — physical pressure and tissue stretch are sufficient triggers for degranulation in sensitized mast cells. When periarticular or connective tissue mast cells degranulate during a stretch, they release histamine, substance P, and prostaglandins into the local environment. This sensitizes neighboring nociceptors further (a process called peripheral sensitization) and triggers the substance P amplification loop: released substance P activates more mast cells, which release more histamine and tryptase, which further lower nociceptor thresholds. A single stretching session can set this cycle in motion.
The nerve sheath problem. A significant proportion of ME/CFS patients — estimates from skin biopsy studies suggest 30–38% — have biopsy-confirmed small fiber neuropathy: damage to the thin, unmyelinated nerve fibers that mediate pain, temperature, and autonomic signals. Many more likely have subclinical nerve sheath involvement. Stretching elongates the nerve trunks within their sheaths. In healthy nerves, this is well-tolerated. In nerves where the endoneurial microvasculature is already impaired (as occurs in ME/CFS through endothelial dysfunction), stretch further reduces already-marginal blood flow within the nerve sheath, intensifying any ischemia-related pain. And in patients with autoimmune contributions to their small fiber neuropathy, stretch-related tension may aggravate an already-inflamed nerve sheath microenvironment.
The metabolic cost. Stretching is not free. It requires muscular activity to control the stretch, resist gravity, and maintain position. This generates the same metabolic profile — lactate accumulation, acidosis, ATP release — that activates ASIC3 and P2X receptors in muscle tissue. For a patient already at or near the threshold where metabolic nociception activates, even the mild muscular effort of a stretching routine can push the system over. And the sustained effort of holding a stretch — particularly isometric stretching — triggers the post-exertional immune response to a degree proportional to the muscular work involved.
Micro-tears and the repair deficit. Any muscle stretch or eccentric contraction — lowering a weight, going downstairs, reaching overhead — causes microscopic damage to muscle fibers. These micro-tears are normal and, in healthy muscles, are the basis of adaptation: the repair process makes the fibers slightly stronger. In ME/CFS, this repair process is severely impaired. The oxidative environment interferes with satellite cell (muscle stem cell) activation. ATP deficit limits protein synthesis. The elevated inflammatory cytokine environment, rather than promoting repair, sustains a low-grade inflammatory state that slows healing. The consequence is that micro-tears which a healthy person resolves in 24–48 hours accumulate in ME/CFS muscle tissue before the previous round of damage has been repaired. Repeated stretching sessions — or any eccentric loading — stack damage on unhealed damage. This is the same mechanism that explains why “pushing through” produces degradation rather than adaptation, now operating at the level of individual muscle fiber architecture.
What this means. This doesn’t mean all movement or gentle mobility work is harmful for everyone with ME/CFS. It means that the intuitive logic — “if I’m stiff, I should stretch; stretching loosens things up” — does not account for the specific biology of this disease. The stiffness in ME/CFS is not primarily caused by tight muscles that need lengthening. It is caused by periarticular mast cell activation, fascial nociceptor sensitization, altered connective tissue chemistry, and a nervous system set to amplify mechanical inputs. Stretching addresses none of these mechanisms and activates several of them.
For some patients, very gentle movement within a highly constrained range — below the threshold that activates any of these systems — provides some symptomatic benefit. But therapeutic exercise prescriptions written for healthy muscles, or for stiffness caused by sedentary lifestyle, are not calibrated to this biology. The person who tried stretching and felt dramatically worse afterward was not doing it wrong. They were doing it with a body that responds to mechanical loading very differently from the body the advice was written for.
10 What this means practically
The fatigue and the pain are not separate symptoms. They arise from the same upstream failure — impaired mitochondrial energy production — through two parallel but intersecting pathways. Energy deficits create both the capacity limit and the metabolic environment that generates nociceptor activation. Central sensitization amplifies both the fatigue signals and the pain signals. Understanding this makes clear why patients cannot simply choose to push through the pain: doing so activates the same TLR4/NF-κB cascade that will produce the delayed crash.
Activity management is not avoidance. The goal of pacing — staying below the threshold that triggers the post-exertional immune response — is physiologically grounded. The threshold corresponds approximately to the anaerobic threshold, the point at which the metabolic shift occurs and the danger-signal profile that activates ASIC3, P2X, and TLR4 begins to build. Remaining below this threshold reduces the magnitude of the subsequent inflammatory response. It is not a behavioral strategy for people who aren’t trying hard enough. It is the mechanistically correct response to a specific biological vulnerability.
“You don’t look sick” is irrelevant. Nothing in this cascade is visible. The metabolic environment inside muscle fibers, the extracellular ATP levels, the microglial activation state, the central sensitization threshold — none of these appear on standard blood tests or imaging. A person can be in genuine physiological distress during activity that appears effortless from the outside.
Simple tasks are genuinely difficult. Peeling potatoes for five minutes requires sustained grip, repetitive forearm movement, and standing or sitting upright — all of which simultaneously activate the metabolic nociception pathway, the fascial tension pathway, the autonomic blood flow disruption pathway, and the periarticular mast cell pathway. And all of these converge on a centrally sensitized nervous system. The resulting pain and fatigue are not out of proportion to the biology. They are the biology.
11 A note on the research
The mechanisms described here draw on studies using exercise testing, gene expression analysis, dolorimetry (objective pain threshold measurement), PET neuroimaging, muscle biopsy, and vascular physiology. The nociceptor biology — ASIC3, P2X, TRPV1 — is well-established in the pain literature and confirmed in ME/CFS by post-exercise gene expression studies. Central sensitization evidence comes from objective pressure pain threshold measurements and conditioned pain modulation testing. Microglial activation is documented by PET imaging. The endothelial and microvascular dysfunction has been confirmed by imaging and functional vascular studies.
This is not a hypothesis built on symptom reporting. It is a chain of biological mechanisms, each with independent empirical support, that produces the clinical picture patients describe.
The people who tell you peeling potatoes left them in pain for three days are not exaggerating. Their muscles were producing a danger-signal chemistry that healthy muscles only generate at high exercise intensities. Their nervous systems were amplifying every signal that arrived. Their immune systems responded to the movement as though it had been a significant physiological stress — because, for them, it was.